Despite the high prevalence of addiction and substance use disorders in the United States, the number of physicians adopting evidence-based substance use disorder interventions in their clinical practice remains low.
Realising the opportunities for growth in the European orphan drug market – Pharmaceutical Technology
The European orphan drug market is growing and is already comparable in size and scope to the US market. The European Union (EU) counts 36